期刊文献+

野生型-p53与JunB融合基因对裸鼠肝细胞肝癌移植瘤的抑制作用 被引量:4

Inhibitory Effect of Fusion Gene of Wild-type p53 and JunB on Growth of Transplanted Hepatocellular Carcinoma in Nude Mice
下载PDF
导出
摘要 目的探讨野生型(wt)-p53与JunB融合基因抑制裸鼠肝细胞肝癌(肝癌)移植瘤的作用。方法将18只BALB/c裸鼠按随机数字表法随机分为实验组、阴性对照组和空白对照组,每组6只,分别接种wt-p53与JunB融合基因质粒、携带GFP的空质粒及单纯肝癌细胞HepG2,于注射后的28d处死荷瘤裸鼠,测量肿瘤体积、肿瘤重量,计算肿瘤抑制率。结果 3组裸鼠移植瘤位于背侧皮下,实验组裸鼠移植瘤较小,阴性对照组与空白对照组裸鼠移植瘤均明显隆起于裸鼠背部皮下。实验组移植瘤的体积、重量明显小于阴性对照组,差异均有统计学意义(LSD-t=4.63,P=0.006;LSD-t=19.56,P<0.01);实验组移植瘤的体积、重量也明显小于空白对照组,差异均有统计学意义(LSD-t=5.74,P=0.002;LSD-t=27.22,P<0.01);阴性对照组与空白对照组间移植瘤的体积、重量差异无统计学意义(LSD-t=1.59,P=0.171;LSD-t=2.00,P=0.101)。实验组平均肿瘤抑制率为84%。结论 wt-p53和JunB融合基因可明显抑制裸鼠肝癌移植瘤的生长。 Objective To examine the inhibitory effect of fusion gene of wild-type p53 and JunB on the growth of transplanted hepatocellular carcinoma in nude mice.Methods Eighteen nude mice were randomly divided into experiment group,negative control group and blank control group(n=6each).They were subcutaneously injected with hepatocellular carcinoma cells transfected with plasmids carrying wt-p53/JunB fusion gene or empty plasmids carrying GFP,or hepatocellular carcinoma cells alone.Twenty-eight days after the injection,the nude mice were sacrificed and the gross tumor volume,the tumor weight and the tumor inhibition rate were obtained.Results The hepatocellular carcinomas were subcutaneously transplanted on the back of the mice.They were significantly protruded in the negative and blank control groups compared with the experiment group.The gross tumor volume and tumor weight were significantly decreased in the experiment group relative to the negative control group(LSD-t=4.63,P=0.006;LSD-t=19.56,P0.01)and the blank control group(LSD-t=5.74,P=0.002;LSD-t = 27.22,P0.01).But there was no significant difference in the gross tumor volume and tumor weight between the negative control group and the blank control group(LSD-t=1.59,P=0.171;LSD-t= 2.00,P=0.101).The tumor inhibition rate of the experimental group was 84%.Conclusion The fusion gene of wt-p53and JunB can significantly inhibit the growth of the transplanted hepatocellular carcinoma in nude mice.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2013年第6期703-706,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.81272645) 中央高校基本科研业务费专项资金资助项目(No.xjj2010010)
关键词 野生型-p53 JUNB 融合基因 转染 HEPG2 裸鼠移植瘤 wild-type p53 JunB fusion gene transfect HepG2 nude mice transplanted tumor
  • 相关文献

参考文献3

二级参考文献55

  • 1MARREIROS A, CZOLIJ R, YARDLEY G, et al. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53 [J]. Gene, 2003, 302(1-2) : 155-164.
  • 2PUCA R, NARDINOCCHI L, BOSSI G, et al. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc [J]. Exp Cell Res, 2009, 315(1) :67-75.
  • 3YANO M, HAMATANI K, EGUCHI H, et al. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes [J]. Eur J Cancer, 2007, 43 (6): 1092-1100.
  • 4ANDRECHT S, KOLBUS A, HARTENSTEIN B, et al. Cell cycle promoting activity of junB through cyclin A activation [J]. J Biol Chem, 2002, 277(39):35961-35968.
  • 5SHAULIAN E, KARIN M. AP-1 as a regulator of cell life and death [J]. Nat Cell Biol, 2002, 4(5):E131-136.
  • 6PASSEGUE E, WAGNER EF. JunB suppresses cell proliferation by transcriptional activation of pl 6 (INK4a) expression [J]. EMBO J, 2000, 19 (12) :2969-2979.
  • 7CHANG YS, YEH KT, YANG MY, et al. Abnormal expression of JUNB gene in hepatocellular carcinoma [J]. Oncol Rep, 2005,13 (3) : 433-438.
  • 8LEE JS, HEO J, LIBBRECHT L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells [J]. Nat Med, 2006, 12(4):410-416.
  • 9MARREIROS A, DUDGEON K, DAO V, et al. KAI1 promoter activity is dependent on p53, junB and AP2 : evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells [J]. Oncogene, 2005, 24(4):637-649.
  • 10Dorigo O, Turla S T, Lebedeva S, et al. Sensitization of rat glioblastoma multiform to cisplatin in vivo following restoration of wild-type p53 function [J]. J Neurosurg, 1998,88(3):535-540.

共引文献24

同被引文献71

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 2姬峻芳,吴旻,詹启敏.Gadd45a在抑制细胞转化和肿瘤恶性进展中的作用[J].生物化学与生物物理进展,2006,33(12):1146-1153. 被引量:11
  • 3Li R,Sutphin D,Schwartz D,et al.Mutant p53 protein ex-pression interferes with Pii-independent apoptotic pathways[J].Oncogene,1998,16(25):3269-3277.
  • 4Stambolsky P,Tabach Y,Fontemaggi G,et al.Modulation ofthe vitamin D3 response by cancer-associated mutant p53[J].Cancer Cell,2010,17(3):273-285.
  • 5Mizuno H,Spike B T,Wahl G M,et al.Inactivation of p53 inbreast cancers correlates with stem cell transcriptional signa-tures[J].Pro Nat Acad Sci USA,2010,107(52):22745-22750.
  • 6Soussi T,Caron de Fromentel C, May P.Structural aspects ofthe p53 protein in relation to gene evolution[J].Oncogene,1990,5(7):945-952.
  • 7Petitjean A,Achatz M I,Borresen-Dale A L,et al.Tp53 mu-tations in human cancers:functional selection and impact oncancer prognosis and outcomes[J].Oncogene,2007,26(15):2157-2165.
  • 8Slee E A,O'Connor D J,Lu X.To die or not to die:how doesp53 decide?[J].Oncogene,2004,23(16):2809-2818.
  • 9Dumay A,Feugeas J P,Wittmer E,et al.Distinct tumor pro-tein p53 mutants in breast cancer subgroups[J].Int J Cancer,2013,132(5):1227-1231.
  • 10Chae S W,Sohn J H,Kim D H,et al.Overexpressions of Cyc-lin BI,cdc2,pi6 and p53 in human breast cancer:the clinico-pathologic correlations and prognostic implications[J].YonseiMed J,2011,52(3):445-453.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部